2011
DOI: 10.1177/0269216310391692
|View full text |Cite
|
Sign up to set email alerts
|

Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data

Abstract: Haematological malignancies are complex diseases, affecting the entire age spectrum, and having marked differences in presentation, treatment, progression and outcome. Patients have a significant symptom burden and despite treatment improvements for some sub-types, many patients die from their disease. We carried out a systematic review and meta-analysis to examine the proportion of patients with haematological malignancies that received any form of specialist palliative or hospice care. Twenty-four studies we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

9
166
0
4

Year Published

2014
2014
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 203 publications
(179 citation statements)
references
References 46 publications
9
166
0
4
Order By: Relevance
“…Amid the growing literature showing that patients with blood cancers have inadequate access to palliative care services, 19,23,[34][35][36] our findings have three important implications. First, targeted education about a more inclusive role for palliative care in hematologic oncology is needed.…”
Section: 33mentioning
confidence: 89%
See 1 more Smart Citation
“…Amid the growing literature showing that patients with blood cancers have inadequate access to palliative care services, 19,23,[34][35][36] our findings have three important implications. First, targeted education about a more inclusive role for palliative care in hematologic oncology is needed.…”
Section: 33mentioning
confidence: 89%
“…Patients with hematologic malignancies have significant palliative care needs, including high symptom burden [15][16][17] ; however, they remain less likely than patients with solid tumors to receive specialist palliative care services and more likely to receive aggressive health care at the end of life. 18 Specifically, patients with blood cancers are less frequent users of hospice services, 19 less likely to be seen by consultative palliative care services in the hospital, 20 more likely to die in a hospital or intensive care unit, [21][22][23] and more likely to receive chemotherapy in the last few weeks of life. 24 These findings point toward unmet palliative care needs in the hematologic malignancy population.…”
mentioning
confidence: 99%
“…Both the manner and setting in which patients with haematological cancers are treated can differ from patients diagnosed with solid tumours [14]. Treatment is comparatively intensive and carries a high burden of illness that can impact upon a person's social, vocational and family functioning [15].…”
Section: Introductionmentioning
confidence: 99%
“…Rather, a growing body of evidence highlights that patients with cancer derive many benefits from palliative care including reductions in symptom burden, 2 improvements in quality-of-life and mood, 3,4 improved survival, 4,5 as well as improved caregiver outcomes 6 ; this is true even for those receiving active cancer treatment. However, patients with hematologic malignancies are much less likely to access palliative care services than patients with solid tumors, 7,8 despite growing evidence of many unmet palliative care needs in this population. 9 This discrepancy suggests a need for more education about palliative care in the hematology community, and more efforts to adapt palliative care services to better meet the needs of patients with hematologic malignancies.…”
mentioning
confidence: 99%